Ovary and Peritoneum

Chapter

Abstract

Pathology of the ovary is complex topic as a wide variety of infrequently encountered inflammatory lesions, other nonneoplastic lesions, and tumors exist. Furthermore, numerous entities exist within each of the major categories of tumors: the surface epithelial tumors, sex cord–stromal tumors, germ cell tumors, and the miscellaneous and secondary tumors. The key histologic features and differential diagnostic considerations of ovarian and peritoneal lesions are discussed.

Keywords

Ovary Peritoneum Ovarian carcinoma Sex cord–stromal tumors Germ cell tumors 
This is a preview of subscription content, log in to check access.

Suggested Reading

  1. Bodurka DC, Deavers MT, Tian C, et al. Reclassification of serous ovarian carcinoma by a 2-tier system. Cancer. 2012;118:3087–94.CrossRefPubMedGoogle Scholar
  2. Buis CCM, van Leeuwen FE, Mooij TM, et al. Increased risk for ovarian cancer and borderline ovarian tumors in subfertile women with endometriosis. Hum Reprod. 2013;28:3358–69.CrossRefPubMedGoogle Scholar
  3. Clement PB. Nonneoplastic lesions of the ovary (Chapter 16). In: Kurman RJ, editor. Blaustein’s pathology of the female genital tract. 5th ed. New York: Springer; 2002a. p. 675–727.Google Scholar
  4. Clement PB. Diseases of the peritoneum (Chapter 17). In: Kurman RJ, editor. Blaustein’s pathology of the female genital tract. 5th ed. New York: Springer; 2002b. p. 729–89.Google Scholar
  5. Cribb B, Vishwanath N, Upadhyay V. Paediatric ovarian lesions—the experience at Starship Children’s Hospital, New Zealand. N Z Med J. 2014;127:41–51.PubMedGoogle Scholar
  6. Crum CP, Herfs M, Ning G, et al. Through the glass darkly: intraepithelial neoplasia, top-down differentiation, and the road to ovarian cancer. J Pathol. 2013;231:402–12.PubMedCentralCrossRefPubMedGoogle Scholar
  7. del Carmen MG, Birrer M, Schorge JO. Carcinosarcoma of the ovary: a review of the literature. Gynecol Oncol. 2012a;125:271–7.CrossRefPubMedGoogle Scholar
  8. del Carmen MG, Birrer M, Schorge JO. Clear cell carcinoma of the ovary: a review of the literature. Gynecol Oncol. 2012b;126:481–90.CrossRefPubMedGoogle Scholar
  9. du Bois A, Ewald-Riegler N, de Gregorio N, et al. Borderline tumors of the ovary: a cohort study of the Arbeitsgmeinschaft Gynäkologische Onkologie (AGO) Study Group. Eur J Cancer. 2013;49:1905–14.CrossRefPubMedGoogle Scholar
  10. Esheba GE, Pate LL, Longacre TA. Oncofetal protein glypican-3 distinguishes yolk sac tumor from clear cell carcinoma of the ovary. Am J Surg Pathol. 2008;32:600–7.CrossRefPubMedGoogle Scholar
  11. Foulkes WD, Clarke BA, Hasselblatt M, et al. No small surprise—small cell carcinoma of the ovary, hypercalcemic type, is a malignant rhabdoid tumor. J Pathol. 2014;233:209–14.CrossRefPubMedGoogle Scholar
  12. Gounaris I, Charnock-Jones DS, Brenton JD. Ovarian clear cell carcinoma—bad endometriosis or bad endometrium? J Pathol. 2011;225:157–60.CrossRefPubMedGoogle Scholar
  13. Khunamornpong S, Settakorn J, Sukpan K, et al. Mucinous tumor of low malignant potential (“borderline” or “atypical proliferative” tumor) of the ovary: a study of 171 cases with the assessment of intraepithelial carcinoma and microinvasion. Int J Gynecol Pathol. 2011;30:218–30.CrossRefPubMedGoogle Scholar
  14. Kohn EC, Romano S, Lee JM. Clinical implications of using molecular diagnostics for ovarian cancers. Ann Oncol. 2013;24 Suppl 10:x22–6.PubMedCentralCrossRefPubMedGoogle Scholar
  15. Kommoss S, Anglesio MS, Mackenzie R, et al. FOXL2 molecular testing in ovarian neoplasms: diagnostic approach and procedural guidelines. Mod Pathol. 2013;26:860–7.CrossRefPubMedGoogle Scholar
  16. Kunkel J, Peng Y, Tao Y, et al. Presence of a sarcomatous component outside the ovary is an adverse prognostic factor for primary ovarian malignant mixed mesodermal/Mullerian tumors: a clinicopathologic study of 47 cases. Am J Surg Pathol. 2012;36:831–7.CrossRefPubMedGoogle Scholar
  17. Kurman RJ. Origin and molecular pathogenesis of ovarian high-grade serous carcinoma. Ann Oncol. 2013;24 Suppl 10:x16–21.CrossRefPubMedGoogle Scholar
  18. Kurman RJ, Carcangiu ML, Herrington CS, Young RH, editors. WHO classification of tumours of female reproductive organs. Lyon: International Agency for Research on Cancer (IARC); 2014.Google Scholar
  19. Lee S, Nelson G, Duan Q, et al. Precursor lesions and prognostic factors in primary peritoneal serous carcinoma. Int J Gynecol Pathol. 2013;32:547–55.CrossRefPubMedGoogle Scholar
  20. Lin JE, Seo S, Kushner DM, et al. The role for appendectomy for mucinous ovarian neoplasms. Am J Obstet Gynecol. 2013;208:46.e1–4.CrossRefGoogle Scholar
  21. Mangili G, Bergamini A, Taccagni G, et al. Unraveling the two entities of endometrioid ovarian cancer: a single center clinical experience. Gynecol Oncol. 2012;126:403–7.CrossRefPubMedGoogle Scholar
  22. McCluggage WG. Immunohistochemistry in the distinction between primary and metastatic ovarian mucinous neoplasms. J Clin Pathol. 2012;65:596–600.CrossRefPubMedGoogle Scholar
  23. Miettinen M, McCue PA, Sarlomo-Rikala M, et al. GATA3: a multispecific but potentially useful marker in surgical pathology: a systemic analysis of 2500 epithelial and nonepithelial tumors. Am J Surg Pathol. 2014;38:13–22.PubMedCentralCrossRefPubMedGoogle Scholar
  24. Offman SL, Longacre TA. Clear cell carcinoma f the female genital tract (not everything is as clear as it seems). Adv Anat Pathol. 2012;19:296–312.CrossRefPubMedGoogle Scholar
  25. Prat J. Ovarian carcinomas: five distinct diseases with different origins, genetic alterations, and clinicopathological features. Virchows Arch. 2012;460:237–49.CrossRefPubMedGoogle Scholar
  26. Rabban JT, Barnes M, Chen LM, et al. Ovarian pathology in risk-reducing salpingo-oophorectomies from women with BRCA mutations, emphasizing the differential diagnosis of occult primary and metastatic carcinoma. Am J Surg Pathol. 2009;33:1125–36.CrossRefPubMedGoogle Scholar
  27. Roth LM. Recent advances in the pathology and classification of ovarian sex cord–stromal tumors. Int J Gynecol Pathol. 2006;25:199–215.CrossRefPubMedGoogle Scholar
  28. Roth LM, Talerman A. Recent advances in the pathology and classification of ovarian germ cell tumors. Int J Gynecol Pathol. 2006;25:305–20.CrossRefPubMedGoogle Scholar
  29. Russell P, Robboy SJ, Anderson MC. The ovaries: normal appearances and nonneoplastic conditions (Chapter 18). In: Robboy SJ, Anderson MC, Russel P, editors. Pathology of the female reproductive tract. Edinburg: Churchill Livingstone; 2002a. p. 475–690.Google Scholar
  30. Russell P, Robboy SJ, Anderson MC. Epithelial/stromal ovarian tumors (Chapter 20). In: Robboy SJ, Anderson MC, Russel P, editors. Pathology of the female reproductive tract. Edinburg: Churchill Livingstone; 2002b. p. 539–605.Google Scholar
  31. Russell P, Robboy SJ, Anderson MC. Sex cord–stromal and steroid cell tumors of the ovaries (Chapter 21). In: Robboy SJ, Anderson MC, Russel P, editors. Pathology of the female reproductive tract. Edinburg: Churchill Livingstone; 2002c. p. 607–40.Google Scholar
  32. Russell P, Robboy SJ, Anderson MC. Germ cell tumors of the ovaries (Chapter 22). In: Robboy SJ, Anderson MC, Russel P, editors. Pathology of the female reproductive tract. Edinburg: Churchill Livingstone; 2002d. p. 641–90.Google Scholar
  33. Seidman JD, Russel P, Kurman RJ. Surface epithelial tumors of the ovary (Chapter 18). In: Kurman RJ, editor. Blaustein’s pathology of the female genital tract. 5th ed. New York: Springer; 2002. p. 791–904.Google Scholar
  34. Tadahisa T, Ohishi Y, Imamura H, et al. Ovarian transitional cell carcinoma represents a poorly differentiated form of high-grade serous or endometrioid adenocarcinoma. Am J Surg Pathol. 2013;37:1091–9.CrossRefGoogle Scholar
  35. Talerman A. Germ cell tumors of the ovary (Chapter 20). In: Kurman RJ, editor. Blaustein’s pathology of the female genital tract. 5th ed. New York: Springer; 2002a. p. 967–1033.Google Scholar
  36. Talerman A. Nonspecific tumors of the ovary, including mesenchymal tumors and malignant lymphoma (Chapter 21). In: Kurman RJ, editor. Blaustein’s pathology of the female genital tract. 5th ed. New York: Springer; 2002b. p. 1035–61.Google Scholar
  37. Thrall MM, Paley P, Pizer E, et al. Patterns of spread and recurrence of sex cord–stromal tumors of the ovary. Gynecol Oncol. 2011;122:242–5.PubMedCentralCrossRefPubMedGoogle Scholar
  38. Ulbright TM, Young RH. Gonadoblastoma and selected other aspects of gonadal pathology in young patients with disorders of sex development. Semin Diagn Pathol. 2014;31:427–40.CrossRefPubMedGoogle Scholar
  39. Young RH, Scully RE. Sex cord–stromal, steroid cell, and other ovarian tumors with endocrine, paraendocrine, and paraneoplastic manifestations (Chapter 19). In: Kurman RJ, editor. Blaustein’s pathology of the female genital tract. 5th ed. New York: Springer; 2002a. p. 905–66.Google Scholar
  40. Young RH, Scully RE. Metastatic tumors of the ovary (Chapter 22). In: Kurman RJ, editor. Blaustein’s pathology of the female genital tract. 5th ed. New York: Springer; 2002b. p. 1063–101.Google Scholar
  41. Zaino RJ, Brady MF, Lele SM, et al. Advanced stage mucinous adenocarcinoma of the ovary is both rare and highly lethal. Cancer. 2011;117:554.62.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2016

Authors and Affiliations

  1. 1.Department of Pathology and Laboratory MedicineIndiana University School of MedicineIndianapolisUSA

Personalised recommendations